Search companies

Live

Tuesday, 17 November 2026 · 581 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Genetic Signatures shareholders appoint John Melki, reject three other EGM resolutions

GSS: $0.079 +5.33% · MC: $16M

Genetic Signatures shareholders appointed John Melki as a non-executive director at an extraordinary meeting, while rejecting three other resolutions. BCAL Diagnostics welcomed the appointment but reiterated its opposition to Genetic Signatures’ proposed merger with Microba, saying the terms do not adequately reflect Genetic Signatures’ contribution and calling for more information and an independent assessment for its shareholders.

Source announcements: 2026-10-28 10:58 to 2026-10-28 16:07 Sydney time
Story updated 2026-10-28 16:10 Sydney time
SourcesResults of 2026 EGM and Appointment of DirectorBDX: BCAL Welcomes Dr John Melki's Appointment to GSS Board
Comments